Home >> Marketplace Directory >> Rosetta Genomics, Precipio commercial partnership, 4/15

Rosetta Genomics, Precipio commercial partnership, 4/15

image_pdfCreate PDF

April 2015—Rosetta Genomics has entered into a co-promotional commercial partnership with Precipio Diagnostics for the sales and marketing of Precipio’s oncology tests, which include bone marrow and peripheral blood testing for hematological malignancies, such as leukemias and lymphomas. These products are being promoted by Rosetta in California, Connecticut, New Jersey, Oklahoma, Texas, Virginia, and Washington, DC, with an expectation to expand nationally over time.

“We are very pleased to partner with Precipio and to include their value-added tests to our growing product portfolio as we are confident our commercial team can effectively market Precipio’s cutting-edge oncology diagnostics services. Moreover, the collaboration with the Yale Department of Pathology offers a significant advantage as it is home to some of the world’s experts in pathology. Their credibility combined with the confidence oncologists have with world-class academic pathologists reading their cases cannot be understated,” Kenneth A. Berlin, Rosetta Genomics’ president and CEO, said in a statement.

Rosetta Genomics , 215-382-9000

CAP TODAY
X